Senior government decision makers share their investment priorities, programs and initiatives for accelerating the pipeline of medical countermeasures against emerging infectious diseases and bioterror threats!
The 11th Emerging Infectious Diseases & Biodefense Vaccines, Therapeutics & Diagnostics, scheduled for June 17-19, 2013, will once again provide the latest information on the Federal government’s biodefense and public health medical countermeasures development, manufacturing and procurement initiatives.
The conference is the ideal venue to interact face-to-face with representatives from Federal agencies tasked with protecting public health. Year after year, the conference brings together the public health and national security agencies, biotech and pharmaceutical industries, and the academic and not-for-profit life CBRN communities to explore strategies for dealing with various challenges, share perspectives, and establish collaboration to further the development of needed medical countermeasures.
- Richard Jaffe, Director, Division of Medical Countermeasure Strategy and Requirements (MCSR), Office of Policy and Planning (OPP), Office of Assistant Secretary for Preparedness and Response (ASPR), DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Go to CONFERENCE WEBSITE
Use/Click this Link to REGISTER TODAY!
10% DISCOUNT CODE: 1366SOCIAL10